Nuclear stocks have been exploding (lol).
SMR surged precisely to a Geneiss fib.
Watching the Golden sister for bounce.
$ 16.68 is the key level of interest.
$ 15.35 below might be an SL shield.
$ 18.84 above is a good first target.
SMR surged precisely to a Geneiss fib.
Watching the Golden sister for bounce.
$ 16.68 is the key level of interest.
$ 15.35 below might be an SL shield.
$ 18.84 above is a good first target.
Trade closed: target reached
PINGPING from ""Give me a ping Vasilly, One Ping Only".
Such a Ping excites that fib AND all of its sisters.
We are even more confident in the rest of the fibs.
.
But will it hold? No way to "know". My rule:
"Not all Pings start a Reversal, but Most reversal Start with a Ping"
So lets see if that will launch the next leg.
==========================================================
.
Trade active
BOOM! 33% gains so farPERFECT launch from our Golden fib.
Exact entry, NO drawdown, trail SL now.
.
Zoom IN (m5) and add a fib to the bounce
Green strip fib series seems to fit the wave nicely.
So we look to the 4.236 as wave target at $23.38.
And we consider the 2.618 as SL shield at $21.44
.
So 33% gains, take some profits, trail stops clos.
Looking for one more push into $23.38 for next TP.
==============================================================
.
Note
54% gains booked, new idea posted for retrace targets:<deleted>
==============================================================
.
the Golden Ratio is my Religion
the Trading View is my Nation
the Moderator Tag is my Flag
the Trading View is my Nation
the Moderator Tag is my Flag
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
the Golden Ratio is my Religion
the Trading View is my Nation
the Moderator Tag is my Flag
the Trading View is my Nation
the Moderator Tag is my Flag
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.